| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 16,303,181 | 14,957,000 | 12,407,982 | | Cost of Revenue | 5,557,037 | 4,966,000 | 4,193,976 | | | Gross Profit | 10,746,143 | 9,991,000 | 8,214,006 | | | Operating Expenses | | Research Development | 2,299,221 | 2,129,000 | 1,761,555 | | Selling General and Administrative | 4,430,687 | 3,871,000 | 3,141,423 | | Non Recurring |
-
|
-
|
-
| | Others | 12,687 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 4,003,548 | 3,991,000 | 3,311,028 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 49,340 | 189,000 | 222,101 | | Earnings Before Interest And Taxes | 4,054,297 | 4,180,000 | 3,533,129 | | Interest Expense | 173,393 | 7,000 | 3,196 | | Income Before Tax | 3,880,904 | 4,173,000 | 3,529,933 | | Income Tax Expense | 1,163,003 | 1,345,000 | 1,057,887 | | Minority Interest | (1,410) | (3,000) | (2,389) | | | | Net Income From Continuing Ops | 2,716,492 | 2,825,000 | 2,469,657 | | | Non-recurring Events | | Discontinued Operations | (83,172) | (22,000) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,633,320 | 2,803,000 | 2,469,657 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,633,320 | $2,803,000 | $2,469,657 |
|
0.32% Nasdaq 
Income Statement
